SHE:301333 - R&G PharmaStudies Co Ltd

R&G PharmaStudies Co. Ltd. A
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2013	2014	2015	2017	2018	2019	2020	2021	2022	2023	Graph
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	677.47M 26.3%	1.88B 178.0%	2.07B 10.1%
Current Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	605.11M 28.0%	1.81B 198.9%	2.01B 10.9%
Cash+Equi+Others	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	361.6M 23.1%	1.52B 321.0%	1.7B 11.9%
NonCurrent Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	72.36M 13.5%	74.47M 2.9%	67.6M -9.2%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	239.66M 20.2%	289.35M 20.7%	319.17M 10.3%
Current Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	234.43M 20.9%	280.52M 19.7%	314.36M 12.1%
NonCurrent Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	5.22M -4.8%	8.82M 68.9%	4.81M -45.5%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	437.81M 29.9%	1.59B 264.0%	1.75B 10.1%
Stockholders Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	422.53M 30.9%	1.59B 275.8%	1.75B 10.1%
Minority Interest	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	15.28M 8.0%	5.97M -60.9%	6.24M 4.4%